Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT

Neoplasia

Volumn 8, Issue 7, 2006, Pages 543-550

  Zhang, Weihua ^a   Tsan, Rachel ^a   Nam, Do Hyun ^a   Lu, Weixin ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adhesion; AKT; Circulation; Melanoma; Organ microenvironment

Indexed keywords

INTERMEDIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

AMELANOTIC MELANOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; MELANOCYTE; MELANOGENESIS; MELANOMA CELL; METASTASIS; MOLECULAR CLONING; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; ROTATION; SUSPENSION CELL CULTURE;

EID: 33745956254     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05655     Document Type: Article

References (35)

1. Fidler IJ (2002). The organ microenvironment and cancer metastasis. Differentiation 70, 498-505.
2. Price JE, Tarin D, and Fidler IJ (1988). Influence of organ microenvironment on pigmentation of a metastatic murine melanoma. Cancer Res 48, 2258-2264.
3. Schackert G and Fidler IJ (1998). Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals. Cancer Res 48, 3478-3483.
4. Fujimaki T, Price JE, Fan D, and Bucana C (1996). Selective growth of human melanoma cells in the brain parenchyma of nude mice. Melanoma Res 6 (5), 363-371.
5. Fidler IJ, Gruys E, Cifone MA, Barnes Z, and Bucana C (1981). Demonstration of multiple phenotypic diversities in a murine melanoma of recent origin. J Natl Cancer Inst 67, 947-956.
6. Radinsky R, Beltran PJ, Tsan R, Zhang R, Cone RD, and Fidler IJ (1995). Transcriptional induction of the melanocyte stimulating hormone receptor in brain metastases of murine K-1735 melanoma. Cancer Res 55, 141-148.
7. Lowings P, Yavuzer U, and Goding CR (1992). Positive and negative elements regulate a melanocyte-specific promoter. Mol Cell Biol 12, 3653-3662.
8. Lei TC, Virador V, Yasumoto K, Vieira WD, Toyofuku K, and Hearing VJ (2002). Stimulation of melanoblast pigmentation by 8-methoxypsoralen: the involvement of microphthalmia-associated transcription factor, the protein kinase a signal pathway, and proteasome-mediated degradation. J Invest Dermatol 119, 1341-1349.
9. Aoki H and Moro O (2002). Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci 71, 2171-2179.
10. Goding CR (2000). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 14, 1712-1728.
11. Kim DS, Kim SY, Chung JH, Kim KH, Eun HC, and Park KC (2002). Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal 14, 779-785.
12. Aplin AE, Howe A, Alahari SK, and Juliano RL (1998). Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 50, 197-263.
13. Giancotti FG and Ruoslahti E (1999). Integrin signaling. Science 285, 1028-1032.
14. Kripke ML (1979). Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 63, 541-548.
15. Fidler IJ and Nicolson GL (1976). Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 57, 1199-1202.
16. Lu W and Schroit AJ (2005). Vascularization of melanoma by mobilization and remodeling of preexisting latent vessels to patency. Cancer Res 65, 913-918.
17. Bruns CJ, Solorzano CC, Harbison MT, Ozawa S, Tsan R, Fan D, Abbruzzese J, Traxler P, Buchdunger E, Radinsky R, et al. (2000). Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res 60, 2926-2935.
18. Wang LH (2004). Molecular signaling regulating anchorage-independent growth of cancer cells. Mt Sinai J Med 71, 361-367.
19. Fidler IJ (2002). The organ microenvironment and cancer metastasis. Differentiation 70, 498-505.
20. Frisch SM and Screaton RA (2001). Anoikis mechanisms. Curr Opin Cell Biol 13, 555-562.
21. 125I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 45, 773-782.
22. Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O'Hara SM, Russell T, and Terstappen LW (2004). Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry, Part A 62, 46-53.
23. Valentijn AJ, Zouq N, and Gilmore AP (2004). Anoikis. Biochem Soc Trans 32, 421-425.
24. Zhan M, Zhao H, and Han ZC (2004). Signaling mechanisms of anoikis. Histol Histopathol 19, 973-983.
25. Widlund HR and Fisher DE (2003). Microphthalmia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 22, 3035-3041.
26. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, Lin YL, Ramaswamy S, Avery W, Ding HF, et al. (2002). Bcl2 regulation by the melanocyte master regulator MITF modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
27. Kim DS, Kim SY, Chung JH, Kim KH, Eun HC, and Park KC (2002). Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal 14, 779-785.
28. Khaled M, Larribere L, Bille K, Aberdam E, Ortonne JP, Ballotti R, and Bertolotto C (2002). Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis. J Biol Chem 277, 33690-33697.
29. Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET, and Medrano EE (2000). Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res 255, 135-143.
30. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351, 781-791.
31. Vlems FA, Ruers TJ, Punt CJ, Ligtenberg MJ, Cornelissen IM, van Krieken JH, Wobbes T, van Muijen GN, and Ruers TJ (2003). Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective. Eur J Surg Oncol 29, 289-302.
32. Fidler IJ and Hart IR (1982). Biological diversity in metastatic neoplasms: origins and implications. Science 217, 998-1003.
33. Macaluso M, Paggi MG, and Giordano A (2003). Genetic and epigenetic alterations as hallmarks of the intricate road to cancer. Oncogene 22, 6472-6478.
34. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, et al. (2005). Global gene expression profiling of circulating tumor cells. Cancer Res 65, 4993-4997.
35. Paget S (1889). The distribution of secondary growths in cancer of the breast. Lancet 1, 571-573.